Abstract
Osteoporosis prevention programs, based on risk assessment, are an important goal both for individual patients and for improved public health. I have reviewed some of the current approaches to such programs and the major questions which must be answered in order to validate these approaches. In particular, new knowledge concerning the usefulness of markers of bone turnover and of the effectiveness of antiresponsive strategies should greatly improve our ability to prevent osteoporotic fractures. Meanwhile, there is enough information to support the concept that risk assessment should be used to develop a cost-effective prevention program and to guide the approach to therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Eisman JA. OsteoPPPorosis: prevention, prevention and prevention. Aust NZ J Med 1991;21:205–9.
Lindsay R. Prevention and treatment of osteoporosis. Lancet 1993;341:801–5.
Slemenda CW, Hui SL, Longcope C, Wellman H, Johnston CC Jr. Predictors of bone mass in perimenopausal women: a prospective study of clinical data using photon absorptiometry. Ann Intern Med 1990;112:96–101.
Black DM, Cummings SR, Genant HK, Nevitt MC, Palermo L, Browner W. Axial and appendicular bone density predict fractures in older women. J Bone Miner Res 1992;7:633–8.
Ross PD, Davis JW, Epstein RS, Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 1991;114:919–23.
Gardsell P, Johnell O, Nilsson BE. The predictive value of bone loss for fragility in women: a longitudinal study over 15 years. Calcif Tissue Int 1991;49:90–4.
Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, et al. Bone density at various sites for prediction of hip fractures. Lancet 1993;341:72–5.
Mallmin H, Ljunghall S, Persson I, Naesson T, Krusemo U-B, Bergstrom R. Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up. Calcif Tissue Int 1993;52:269–72.
Vanhemert AM, Vandenbroucke JP, Birkenhager JC, Valkenburg HA. Prediction of osteoporotic fractures in the general population by a fracture risk score: a 9-year follow-up among middle-aged women. Am J Epidemiol 1990;132:123–35.
Blumsohn A, Eastell R. Prediction of bone loss in postmenopausal women. Eur J Clin Invest 1992;22:764–6.
Tosteson ANA, Rosenthal DI, Melton LJ III, Weinstein MC. Cost effectivemess of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy. Ann Intern Med 1990;113:594–603.
Rubin SM, Cummings SR. Results of bone densitometry affect women's decisions about taking measures to prevent fractures. Ann Intern Med 1992;116:990–5.
Cheung AP, Wren BG. A cost-effectiveness analysis of hormone replacement therapy in the menopause. Med J Aust 1992;156:312–6.
Levy E. Cost analysis of osteoporosis related to untreated menopause. Clin Rheumatol 1989;8:76–82.
Janis JA, Johnell O, Gullberg B, Allander E, Dilsen G, Gennari C, et al. Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. BMJ 1992;305:1124–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Raisz, L.G. Assessment of the risk of osteoporosis at the menopause: Therapeutic consequences. Osteoporosis Int 4 (Suppl 1), S53–S57 (1994). https://doi.org/10.1007/BF01623437
Issue Date:
DOI: https://doi.org/10.1007/BF01623437